The purpose of the Flow Cytometry and Functional Immunology Research Core is to provide a centralizedresource of technical expertise and major equipment to support and enhance the experimental design andexecution of basic and clinical research in HIV pathogenesis that require application of flow cytometricphenotypic analysis, cell sorting, and/or evaluation of specific immune cell functions. A prime goal is toprovide the intellectual environment and the material resources to enable junior investigators to apply flowcytometry technology to their projects and to encourage established investigators to initiate innovative pilotstudies. To achieve these objectives, expert consultation is provided through the Core Director, AssociateDirectors, and technical supervisor; major instruments are selected for complementary functions;equipment use is accessible through dedicated technician operators; services are provided on a rechargebasis; generated data are analyzed, reduced, and diagramed; and fiscal support is given to pilot andexploratory research projects through the provision of research reagents and instrument time. CFARresources have enabled the Core to support a wide array of HIV research encompassing basic projects onviral regulation and mechanisms of pathogenesis to preclinical development of vaccines and genetherapies, and clinical studies of primary infection, opportunistic infections, neurobiology, and immune andviral responses to vaccines and HAART.To maintain our flow cytometry facility to meet the needs of the San Diego academic research community,several funding sources have been integrated for cooperative support: the UCSD Center for AIDSResearch (CFAR), the VA Research Center for AIDS and HIV Infection (RCAHI), and the Veterans AffairsMedical Research Foundation (VMRF). In addition to principal investigators based at UCSD and the VAMedical Center, investigators from The Scripps Research Institute, the Salk Institute, the La Jolla Instituteof Allergy and Immunology, and the Burnham Institute also utilize the resources provided by our centralfacility. Local use of flow cytometric technology continues to grow and diversify, and the Core facility strivesto keep up with the growing demand. The CFAR award remains an integral component in this endeavor.Application of flow cytometry to several areas of biomolecular research, in addition to expandedapplications in clinical research, makes continued CFAR support crucial to providing the infrastructure totake advantage of new scientific opportunities in HIV research.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
2P30AI036214-14
Application #
7278947
Study Section
Special Emphasis Panel (ZAI1-EC-A (J1))
Project Start
2007-06-01
Project End
2012-05-31
Budget Start
2007-06-01
Budget End
2008-05-31
Support Year
14
Fiscal Year
2007
Total Cost
$366,345
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Heldt, Sven; Prattes, Juergen; Eigl, Susanne et al. (2018) Diagnosis of invasive aspergillosis in hematological malignancy patients: Performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and bronchoalveolar lavage samples. J Infect 77:235-241
Garfein, Richard S; Liu, Lin; Cuevas-Mota, Jazmine et al. (2018) Tuberculosis Treatment Monitoring by Video Directly Observed Therapy in 5 Health Districts, California, USA. Emerg Infect Dis 24:1806-1815
Canan, Chelsea E; Chander, Geetanjali; Monroe, Anne K et al. (2018) High-Risk Prescription Opioid Use Among People Living With HIV. J Acquir Immune Defic Syndr 78:283-290
Jenks, Jeffrey Daniel; Hoenigl, Martin (2018) CD4:CD8 ratio and CD8+ cell count for prognosticating mortality in HIV-infected patients on antiretroviral therapy. J Lab Precis Med 3:
White, Cory H; Beliakova-Bethell, Nadejda; Lada, Steven M et al. (2018) Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment. Front Immunol 9:603
Jiang, Wei; Luo, Zhenwu; Martin, Lisa et al. (2018) Drug Use is Associated with Anti-CD4 IgG-mediated CD4+ T Cell Death and Poor CD4+ T Cell Recovery in Viral-suppressive HIV-infected Individuals Under Antiretroviral Therapy. Curr HIV Res 16:143-150
Gianella, Sara; Marconi, Vincent C; Berzins, Baiba et al. (2018) Genital HIV-1 Shedding With Dolutegravir (DTG) Plus Lamivudine (3TC) Dual Therapy. J Acquir Immune Defic Syndr 79:e112-e114
Innes, Steve; Patel, Kunjal (2018) Noncommunicable diseases in adolescents with perinatally acquired HIV-1 infection in high-income and low-income settings. Curr Opin HIV AIDS 13:187-195
Morales, Mario; Rafful, Claudia; Gaines, Tommi L et al. (2018) Factors associated with extrajudicial arrest for syringe possession: results of a department-wide survey of municipal police in Tijuana, Mexico. BMC Int Health Hum Rights 18:36
Rhodes, Tim (2018) The becoming of methadone in Kenya: How an intervention's implementation constitutes recovery potential. Soc Sci Med 201:71-79

Showing the most recent 10 out of 921 publications